We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Sareum Holdings Plc | LSE:SAR | London | Ordinary Share | GB00BMC3RJ87 | ORD GBP 0.0125 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-3.75 | -25.86% | 10.75 | 10.50 | 11.00 | 12.00 | 10.50 | 12.00 | 7,622,267 | 16:22:50 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -3.19M | -0.0469 | -2.35 | 7.49M |
Date | Subject | Author | Discuss |
---|---|---|---|
24/7/2022 18:31 | I have a few here. lol🤗 | barkbooo | |
24/7/2022 18:24 | His broker has a load too, and both here for the end game, which they will tell you could still be some way off. | horridhenry | |
24/7/2022 18:22 | ‘This will upset the resident troll’ Fingers crossed! 🤣 Not that I’ll get to see it having a strop though but the fact it’ll say ‘filtered̵ | norma_stitts | |
24/7/2022 18:21 | My mate who originally put me on to this, has 1m, and has taken more than £1m in profit over the years. | horridhenry | |
24/7/2022 18:17 | This will upset the resident troll | horridhenry | |
24/7/2022 18:16 | !! I would need to pay Mrs H half to go. No, she can stay, but we get a housekeeper. | horridhenry | |
24/7/2022 17:42 | Henry isnt two billion £30 a share.My little 200 k looks miniscule against you lot but I would walk away happy as a pig in muck with that.If only. | silvergreyhead1 | |
24/7/2022 17:19 | Yes £15 per share sees my kids wealthy. | horridhenry | |
24/7/2022 16:35 | I could live with a £2bn offer, that’d see me with £5m. That’ll do pig, that’ll do. | norma_stitts | |
24/7/2022 16:03 | Hope your spider sense is right Norma would be nice to see this start moving again.Sareum has to do something over these next 12 to 18 months. They have to prove they can move things on and create value for shareholders.And if anyone asks why 12 to 18 months it's because I need some money by then.Get things into the clinics and accept the first 2 billion offer that comes along. | silvergreyhead1 | |
24/7/2022 10:35 | This has to be our year...surely... | gekko2023 | |
24/7/2022 08:30 | Norma is quite correct...so many consecutive months of positive RNS...then silence..dead silence...something is happening! Many Happy returns chaps... x | gekko2023 | |
23/7/2022 23:15 | The silence certainly is deafening. Next week it will be exactly a year since we heard anything about COVID/Agile and the average rate of RNS’ is MASSIVELY down when compared to historical averages. My spider senses are tingling. 🕷 | norma_stitts | |
23/7/2022 21:52 | The silence is deafening Norma. I can' only see the silence from our BOD who are in agreement with The Code (RNS Last August...did post it here as a reminder) leads me to consider that NDAs are apparent and only NEDs can legally make any comment on msm, which is all we have seen albeit rnss re acknowledgement of SO/GSK dealings. I seriously hope its not a takeover. We the shareholders after the consolidation drop in share price (suspicious imo especially when I'm guessing 'they' bought a certain directors share sell for leverage and probably had been buying prior to the citrus skin hunt appointment) deserve what they stipulate as ensuring shareholder interests are respected. Pretty sure a similar thing is happening at Novacyt. But I like to think there is some integrity here. What a blow to a group of clever chaps who built up sareum on the back end of committed shareholders it would be if they sold out to big pharma without standing their ground and getting real value for 'us'. Mateys movement to assist Midatexh as CEO is 'timely' given he is pretty much a lone wolf in big pharma with extraordinary experience. Why would he take a new ceo position if he didn't have more time on his hands..would have thought with the cta he was rather busy....that is unless things have been on licensed under ndas and the great team have worked with them to tweak the trials with their newly acquired pipelines..... Stand by my point that if sareum do well so will GSK. So I have put 20k in here this month on top of previous holding and have a good holding of GSK/Haleon. Let's see what happens. PS the filter on here works a treat! All best Steadydanny | criticalthinker1 | |
23/7/2022 16:42 | I firmly expect something substantive in the next 3 weeks. I’ll not be too shocked if it’s this week? 👍 | norma_stitts | |
23/7/2022 11:25 | Kris - you're lowering my average! | barkbooo | |
22/7/2022 21:24 | Selleckchem.com CCT 245737 Mouse oral bioavailability is complete (100%) with extensive tumor exposure. CCT245737 shows significant single-agent activity against a MYC-driven mouse model of B-cell lymphoma. An i.v. dose of 10mg/kg CCT245737 into BALB/c mice gives a peak plasma concentration of 4μmol/L, with a half-life of 2.86h, an AUC0-∞ of 9.96μmol.h/L, a plasma clearance of 2.1L/h/kg and a large volume of distribution (0.19L). The equivalent oral dose gave an almost identical profile with an AUC0-∞ of 10.4μmol.h/L showing complete oral bioavailability (F = 105%). In a word, CCT245737 shows complete oral bioavailability with linear pharmacokinetics and high tumor/plasma ratios consistent with extensive tumor exposure. Adequate CCT245737 tumor drug exposure takes a significant antitumor activity[1]. Great catch up today. Best wishes to the nice/genuine investors. Gsk t/o of S/o as I mentioned was never purely about momo. That's a definite! ;-) Steadydanny | criticalthinker1 | |
22/7/2022 20:30 | I hope so Kris ..sareum have many compounds...sareum healing the world (c) | gekko2023 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions